Clinical Impact of <i>STK11</i> Mutation in Advanced-Stage Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Impact of <i>STK11</i> Mutation in Advanced-Stage Non-Small-Cell Lung Cancer

Published:2022 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Rosellini Pietro,Amintas Samuel,Caumont Charline,Veillon Remi,Galland-Girodet Sigolène,Cuguillière Alain,Nguyen Laurent,Domblides Charlotte,Gouverneur Amandine,Merlio Jean-Philippe,Bezin Julien,Girodet Pierre-Olivier

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference96 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F Bray;CA Cancer J Clin,2018

2. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;R S Herbst;Lancet,2016

3. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer;H Borghaei;N Engl J Med,2015

4. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer;J Brahmer;N Engl J Med,2015

5. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial;A Rittmeyer;Lancet,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP